Retina

Anti-VEGF therapy pegaptanib is efficacious and non-toxic for patients with retinopathy of prematurity (ROP), states a recent study.

Chronic diabetic macula oedema (DME) treatment Iluvien, developed by Alimera Sciences, has obtained marketing authorization in Germany.

Novartis sponsored a symposium at the COPHy congress in 2012 exploring the current treatment issues surrounding wet AMD. This supplement reveals the highlights of the meeting.

Intravitreal bevacizumab (IVB) provide sustained and effective treatment for myopic choroidal neovascularization (mCNV).

Bleb injections of subconjunctival chemotherapy lower the risk of developing orbital tumours in patients with retinoblastoma.

The microperimeter (MP-1) is ideal for detecting early retinal sensitivity loss in diabetic patients.

Intravitreal ranibizumab improves visual acuity and anatomic changes in AMD.

Fight for Sight has donated £1.6 million towards ten research grants focused on tackling sight loss and eye disease treatment.

JP Medical Ltd has announced the release of The Sclera and Systemic Disorders, available now.

A thin choroid at the upper border of the inferior staphyloma is linked to serous retinal detachment development.

The rate of change in flicker sensitivities is helpful in predicting geographic atrophy (GA)

It is possible for AMD patients to maintain BCVA for fives years after macular translocation surgery..

The combination of diabetes and hypertension-potentiated retinal oxidative and inflammatory stress accelerates retinal cell death and acellular capillary formation.

New anatomic characteristics of peripapillary intrachoroidal cavitation have been identified using optical coherence tomography (OCT).

The warning signs of childhood eye cancer retinoblastoma will be included in the new edition of the Personal Child Health Record.

Focal lamina cribrosa (LC) occurs in conjunction with neuroretinal rim and visual field loss.

Ozurdex has been accepted by the Scottish Medicines Consortium for use within the NHS in Scotland.

The perfluoro-n-octane (PFO) tamponade is a safe and effective short-term vitreous substitute in primary rhegmatogenous retinal detachment repair

Peripheral yellow corneal rings are more common in age-related macular degeneration (AMD).

Advanced Retinal Therapy will be held in Vienna, Austria on 3 December 2011. At this event updates, trends and controversies in retinal tehrapy will be discussed in symposia, key-note lectures and a panel discussion session.

The National Institute for Health and Clinical Excellence (NICE) has recommended Ozurdex for the treatment of macular oedema caused by central retinal vein occlusion (CRVO).

Anticoagulation (warafin) therapy was linked to a higher risk of post vitreoretinal surgery (VRS) bleeding in comparison with antipletelet (aspirin, clopidogrel) therapy vitreoretinal.

Anti-vascular endothelial growth factor agent well-tolerated, met primary efficacy endpoint.

The answer may be found in the masking effects of catract upon pre-existing disease

OTEurope speaks with Dr Wolfgang Schalch about 'Critical parameters for lutein delivery systems' and the Actilease system.